DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Dickler MN, Barry WT, Cirrincione CT. et al.
Phase III trial evaluating letrozole as first-line endocrine therapy with or without bevacizumab for the treatment of postmenopausal women with hormone receptor-positive advanced-stage breast cancer: CALGB 40503 (Alliance).
J Clin Oncol 2016;
34: 2602-2609
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.